Top Markets
Coin of the day
Paion AG Paion AG

Paion AG

PA8
Rank in Stocks #35969
Paion AG is a specialized pharmaceutical firm engaged in the global development... Paion AG is a specialized pharmaceutical firm engaged in the global development and commercialization of medicines for hospital settings, specifically addressing needs in sedation, anesthesia, and critical care. Its primary compound, Remimazolam, is an ultra-short-acting intravenous benzodiazepine designed as a sedative/anesthetic, currently progressing through clinical trials for applications in procedural sedation, general anesthesia, and intensive care unit sedation. The company's pipeline also includes Angiotensin II, a vasoconstrictor for treating severe low blood pressure in adults experiencing septic or other forms of distributive shock, and Eravacycline, a new fluorocycline antibiotic targeting complex intra-abdominal infections in adults. Paion AG collaborates with various partners through licensing and strategic agreements, including Cosmo Pharmaceuticals, Wuhan Humanwell Innovative Drug Research and Development Center Limited Company, Hana Pharm, Yichang Humanwell, and Mundipharma. Established in 2000, Paion AG operates from Aachen, Germany.
Share Price
$0.42701586
Last synced: 2023-11-01
Market Cap
$3.21M
Change (1 day)
16.99%
Change (1 year)
0.00%
Country
DE
Trade Paion AG (PA8)

Category

Stock price history for Paion AG (PA8)
Highest end of day price: $0.43 on 2023-11-01

Lowest end of day price: $9.35 on 2022-11-01
Stock price history of Paion AG from 2022 to 2026
Annual Stock Price Performance
Year Performance
2023 -93.62%
2022 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$171.67 -
DE
$161.67 23.26%
DE
$36.61 22.16%
JP
$225.00 37.51%
CH
$21.30 13.79%
IN